The FDA has approved the first generic low molecular weight heparin product -- a generic version of Lovenox (enoxaparin sodium injection) for the prevention of deep vein thrombosis.
The FDA has approved the first generic low molecular weight heparin product -- a generic version of Lovenox (enoxaparin sodium injection) for the prevention of deep vein thrombosis.